Enhanced cognitive performance of dopamine D3 receptor " knock-out" mice in the step-through passive-avoidance test: Assessing the role of the endocannabinoid/endovanilloid systems

Pharmacological Research

Volumn 61, Issue 6, 2010, Pages 531-536

  Micale, Vincenzo ^a   Cristino, Luigia ^b   Tamburella, Alessandra ^a   Petrosino, Stefania ^b   Leggio, Gian Marco ^a   Di Marzo, Vincenzo ^b   Drago, Filippo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CNR   (Italy)

Author keywords

CB1 receptors; D3 receptor; Dopamine; Memory; Rimonabant; TRPV1

Indexed keywords

4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; AMYLOID BETA PROTEIN[1-42]; CANNABINOID 1 RECEPTOR; DOPAMINE 3 RECEPTOR; ENDOCANNABINOID; RIMONABANT; VANILLOID RECEPTOR 1;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; GENOTYPE; KNOCKOUT MOUSE; LEARNING; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANILIDES; ANIMALS; CINNAMATES; COGNITION; MICE; MICE, KNOCKOUT; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D3; TRPV CATION CHANNELS;

EID: 77952887544     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.02.003     Document Type: Article

References (40)

1. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990, 347:146-151.
2. Sigala S., Missale C., Spano P. Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat. Eur J Pharmacol 1997, 336:107-112.
3. Glickstein S.B., Hof P.R., Schmauss C. Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits. J Neurosci 2002, 22:5619-5629.
4. Glickstein S.B., Desteno D.A., Hof P.R., Schmauss C. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb Cortex 2005, 15:1016-1024.
5. Laszy J., Laszlovszky I., Gyertyán I. Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats. Psychopharamacology 2005, 179:567-575.
6. Lacroix L.P., Ceolin L., Zocchi A., Varnier G., Garzotti M., Curcuruto O., et al. Selective dopamine D3 receptor antagonists enhance cortical acetylcholine levels measured with high-performance liquid chromatography/tandem mass spectrometry without anti-cholinesterases. J Neurosci Methods 2006, 157:25-31.
7. Millan M.J., Di Cara B., Dekeyne A., Panayi F., De Groote L., Sicard D., et al. Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis. J Neurochem 2007, 100:1047-1061.
8. Loiseau F., Millan M.J. Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists. Eur Neuropsychopharmacol 2009, 19:23-33.
9. Di Marzo V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 2009, 60:77-84.
10. Micale V., Mazzola C., Drago F. Endocannabinoids and neurodegenerative diseases. Pharmacol Res 2007, 56:382-392.
11. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003, 4:873-884.
12. Starowicz K., Maione S., Cristino L., Palazzo E., Marabese I., Rossi F., et al. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci 2007, 27:13739-13749.
13. van der Stelt M., Di Marzo V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol 2003, 480:133-150.
14. Laviolette S.R., Grace A.A. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell Mol Life Sci 2006, 63:1597-1613.
15. Starowicz K., Cristino L., Di Marzo V. TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr Pharm Des 2008, 14:42-54.
16. Micale V., Cristino L., Tamburella A., Petrosino S., Leggio G.M., Drago F., et al. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: possible involvement of the endocannabinoid and endovanilloid systems. Neurobiol Dis 2009, 36:70-80.
17. Leggio G.M., Micale V., Drago F. Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST). Eur Neuropsychopharmacol 2008, 18:271-277.
18. Holland P.C., Bouton M.E. Hippocampus and context in classical conditioning. Curr Opin Neurobiol 1999, 9:195-202.
19. Mazzola C., Micale V., Drago F. Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol 2003, 477:219-225.
20. Micale V., Leggio G.M., Mazzola C., Drago F. Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia. Brain Res 2006, 1121:207-215.
21. van der Stelt M., Mazzola C., Esposito G., Matias I., Petrosino S., De Filippis D., et al. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci 2006, 63:1410-1424.
22. Gibbs M.E., Maksel D., Gibbs Z., Hou X., Summers R.J., Small D.H. Memory loss caused by beta-amyloid protein is rescued by a beta(3)-adrenoceptor agonist. Neurobiol Aging 2010, 31:614-624.
23. Accili D., Fishburn C.S., Drago J., Steiner H., Lachowicz J.E., Park B.H., et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 1996, 93:1945-1949.
24. Venault P., Chapouthier G., de Carvalho L.P., Simiand J., Morre M., Dodd R.H., et al. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 1986, 321:864-866.
25. Wotjak C.T. Role of endogenous cannabinoids in cognition and emotionality. Mini Rev Med Chem 2005, 5:659-670.
26. Pattij T., Wiskerke J., Schoffelmeer A.N. Cannabinoid modulation of executive functions. Eur J Pharmacol 2008, 585:458-463.
27. Li H.B., Mao R.R., Zhang J.C., Yang Y., Cao J., Xu L. Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol Psychiatry 2008, 64:286-292.
28. Maurice T., Lockhart B.P., Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 1996, 706:181-193.
29. Harkany T., Hortobágyi T., Sasvári M., Kónya C., Penke B., Luiten P.G., et al. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 1999, 23:963-1008.
30. Castorina A., Leggio G.M., Carnazza M.L., Drago F., D'agata V. Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice. Proceedings of the 38th annual meeting of society for neuroscience 2008, Progr No. 685.6/SS46.
31. Walsh D.M., Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004, 44:181-193.
32. Palop J.J., Chin J., Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature 2006, 443:768-773.
33. Gessa G.L., Mascia M.S., Casu M.A., Carta G. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. Eur J Pharmacol 1997, 327:R1-R2.
34. Lichtman A.H. SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur J Pharmacol 2000, 404:175-179.
35. Tzavara E.T., Davis R.J., Perry K.W., Li X., Salhoff C., Bymaster F.P., et al. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 2003, 138:544-553.
36. Levant B. The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 1997, 49:231-252.
37. Koeltzow T.E., Xu M., Cooper D.C., Hu X.T., Tonegawa S., Wolf M.E., et al. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci 1998, 18:2231-2238.
38. Joseph J.D., Wang Y.M., Miles P.R., Budygin E.A., Picetti R., Gainetdinov R.R., et al. Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience 2002, 112:39-49.
39. El-Ghundi M., O'Dowd B.F., George S.R. Insights into the role of dopamine receptor systems in learning and memory. Rev Neurosci 2007, 18:37-66.
40. Pritchard L.M., Logue A.D., Hayes S., Welge J.A., Xu M., Zhang J., et al. 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment. Neuropsychopharmacology 2003, 28:100-107.